30.10.2012 Views

Mapping of Italian research excellence in Neurodegenerative - Apre

Mapping of Italian research excellence in Neurodegenerative - Apre

Mapping of Italian research excellence in Neurodegenerative - Apre

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Nome Tanganelli Sergio<br />

Contatti<br />

tgs@unife.it<br />

Istituto/Dipartimento Dept. <strong>of</strong> Cl<strong>in</strong>ical and Experimental Medic<strong>in</strong>e<br />

Pharmacology Section, University <strong>of</strong> Ferrara, Italy<br />

Proposta di ricerca<br />

Area di <strong>in</strong>teresse identificata<br />

F<strong>in</strong>anziamenti ricevuti<br />

Titolo progetto<br />

Ente f<strong>in</strong>anziatore<br />

Durata progetto<br />

Abstract del progetto<br />

Mechanisms <strong>of</strong> Neurodegeneration : A. Macromolecular <strong>in</strong>teractions and<br />

Neurodegeneration<br />

Neurotens<strong>in</strong> and neurotens<strong>in</strong> antagonist <strong>in</strong> an animal model <strong>of</strong> Park<strong>in</strong>son’s<br />

disease: therapeutic perspectives and role <strong>of</strong> NMDA/neurotens<strong>in</strong> <strong>in</strong>teraction.<br />

San<strong>of</strong>i-Aventis<br />

2007-2010<br />

The tridecapeptide neurotens<strong>in</strong> (NT) significantly enhances glutamatergic<br />

signal<strong>in</strong>g <strong>in</strong> different bra<strong>in</strong> areas and amplifies the NMDA-receptor signal<strong>in</strong>g,<br />

probably by activat<strong>in</strong>g the high-aff<strong>in</strong>ity neurotens<strong>in</strong> receptor (NTS1), as shown by<br />

the NTS1receptor antagonist SR48692-<strong>in</strong>duced counteraction <strong>of</strong> this effect.<br />

These f<strong>in</strong>d<strong>in</strong>gs suggest a re<strong>in</strong>forc<strong>in</strong>g action <strong>of</strong> NT on several functions exerted by<br />

glutamate <strong>in</strong> the central nervous system, <strong>in</strong> particular on the glutamatemediated<br />

excitotoxicity. NT could be implicated <strong>in</strong> the pathogenesis <strong>of</strong> chronic<br />

and acute neurodegenerative disorders, such as Park<strong>in</strong>son’s disease. To further<br />

<strong>in</strong>vestigate this hypothesis, the aims <strong>of</strong> the project, which will comb<strong>in</strong>e<br />

biochemical, functional, morphological and behavioral experiments, will be<br />

evaluate: 1) the putative neuroprotective effects <strong>of</strong> a pretreatment with SR48692<br />

(systemically adm<strong>in</strong>istered) <strong>in</strong> an animal model <strong>of</strong> Park<strong>in</strong>son’s disease [unilateral<br />

6-hydroxydopam<strong>in</strong>e (6-OHDA) lesion]; 2) the functional and physio-pathological<br />

relevance <strong>of</strong> NMDA/NT receptor <strong>in</strong>teractions <strong>in</strong> the striatum <strong>of</strong> naïve and 6-<br />

OHDA -lesioned rats.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!